Navigation Links
Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18

e); and VaIN (any grade) related to vaccine HPV types in those who were PCR negative and seronegative at baseline (Table 1). Table 1 Analysis of Efficacy of GARDASIL in the PPE* Population** ---------------------------------------------------------------------- GARDASIL Placebo ---------------------- Population Number Number % Efficacy (95% CI) n of n of cases cases ====================================================================== HPV 16- or 18-related CIN 2/3 or AIS ---------------------------------------------------------------------- Protocol 005*** 755 0 750 12 100.0 (65.1, 100.0) ---------------------------------------------------------------------- Protocol 007 231 0 230 1 100.0 (-3734.9, 100.0) ---------------------------------------------------------------------- FUTURE I 2200 0 2222 19 100.0 (78.5, 100.0) ---------------------------------------------------------------------- FUTURE II 5301 0 5258 21 100.0+ (80.9, 100.0) ---------------------------------------------------------------------- Combined Protocols++ 8487 0 8460 53 100.0+ (92.9, 100.0) ------------------------------------------------====================== HPV 6-, 11-, 16-, 18-related CIN (CIN 1, CIN 2/3) or AIS ---------------------------------------------------------------------- Protocol 007 235 0 233 3 100.0 (-137.8, 100.0) ---------------------------------------------------------------------- FUTURE I 2240 0 2258 37 100.0+ (89.5, 100.0) ---------------------------------------------------------------------- FUTURE II 5383 4 5370 43 90.7 (74.4, 97.6) ---------------------------------------------
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:9/2/2015)... BioPharmX Corporation (NYSE MKT: BPMX) a Silicon Valley-based ... chief executive officer and co-founder of BioPharmX, will present at ... place, September 8-10, 2015 at The St. Regis Hotel, ... scheduled to present on September 10 from 2:10 to 2:35 ... A live webcast of the presentation will be ...
(Date:9/2/2015)... 2, 2015 Tumultuous market conditions – including ... care M&A activity – have led more than half ... pharmaceutical sales reps. This marks the first time that ... the halfway point, according to the spring 2015 ... ZS . AccessMonitor™ aggregates ...
(Date:9/2/2015)... , Sept. 2, 2015  Kastle Therapeutics (Kastle), ... commercializing pharmaceuticals for diseases with high unmet medical ... executives to key commercial operating positions. ... President, Commercial; Sean was previously Global Marketing Director ... appointed as Director, Commercial Strategy and Analytics; Nick ...
Breaking Medicine Technology:Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5Kastle Therapeutics Announces Key Additions to Commercial Leadership 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 3
... 7, 2011 Akorn, Inc. (NASDAQ: AKRX ... 2011, to discuss third quarter 2011 results followed by a ... day before the market opens. Subject: , Akorn, Inc. ... 2011, at 10:00 a.m. Eastern TimeDomestic Callers: , (888) ...
... PARSIPPANY, N.J., Oct. 7, 2011 Watson Pharmaceuticals, Inc. ... subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated ... Drug Administration (FDA) seeking approval to market Morphine Sulfate ... mg/2 mg, 60 mg/2.4 mg, 80 mg/3.2 mg, and ...
Cached Medicine Technology:Watson Confirms EMBEDA(R) Patent Challenge 2Watson Confirms EMBEDA(R) Patent Challenge 3
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... reputation for the telling the truth about medicine and health, truths that other ... video blog, where he plans to regularly debunk certain misconceptions surrounding cholesterol, metabolically ...
(Date:9/1/2015)... , ... September 01, 2015 , ... For many men, the first thing they notice ... were often forced to wear a looser fitting shirt with a collar that doesn’t close ... a finger between their collar and skin all day because it’s uncomfortable. Now men ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Economics, the author explained how many dental practices across the country are switching ... Manufacturing) technology. According to Beverly Hills cosmetic dentist Dr. Sam Saleh of Ora ...
(Date:9/1/2015)... ... 2015 , ... The Journal of Pain Research has published the ... , As corresponding author Mr Christopher Malone says “Migraine headache is a painful chronic ... to better understand how migraine headaches impact the lives of migraineurs. We asked migraineurs ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... According ... Medical Association, individuals with type 2 diabetes that participated in a three year study ... three years down the line if they elected weight loss surgery at the onset ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2
... 19 Delta Dental of Illinois has ... of Illinois at Chicago,College of Dentistry to ... renovations are complete, the clinic will be ... Dentistry Clinic., (Photo: http://www.newscom.com/cgi-bin/prnh/20071219/AQW128 ), ...
... Ind., Dec. 19 Zimmer Holdings, Inc.,(NYSE: ZMH ... announced,today it will be participating in the 26th Annual ... at 12:00 p.m. Eastern Time., A live webcast ... website at http://investor.zimmer.com . The webcast will,be archived ...
... takes the first step in offering nationwide services, ... announced its plan to expand its services to four ... Area during,the summer of 2007, and is now expanding ... The company hosts a website where healthcare,providers and patients ...
... (MGH) researchers have identified a new molecular pathway that ... This early-stage kidney disease affects 100 million people around ... the kidneys filtering structures. Blocking this pathway could ... slow the process of kidney failure. The research ...
... Device might aid in the detection and monitoring of cancer, ... U.S. team has developed a microchip device that can detect ... has a silicon chip with about 80,000 microscopic posts. Each ... expressed by most solid tumors. The device is able to ...
... Massachusetts General Hospital (MGH) Biomicroelectromechanical Systems (BioMEMS) Resource Center ... device that can isolate, enumerate and analyze circulating tumor ... viable cells from solid tumors carried in the bloodstream ... Because of their rarity and fragility, it has ...
Cached Medicine News:Health News:Delta Dental of Illinois Announces Major Gift to University of Illinois at Chicago College of Dentistry 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 3Health News:Microchip Spots Stray Tumor Cells in the Bloodstream 2Health News:Microchip-based device can detect rare tumor cells in bloodstream 2Health News:Microchip-based device can detect rare tumor cells in bloodstream 3
... Osteopal V is a low viscosity bone ... in vertebroplasty. The bone cement is injected ... purposes. Osteopal V is used for the ... of zirconium dioxide is included in the ...
Based on the trusted Schaltenbrand-Wahren Atlas for Stereotaxy of the human brain, Atlasplan Software provides anatomical detail of the basal ganglia region of the brain and can help confirm target a...
... a comprehensive platform for standard neurosurgical ... to plan the optimal surgical path ... Combined with unique features such as ... planning tool, Neurosight becomes a very ...
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with our displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless...
Medicine Products: